Manufacturer profile
Armas Pharmaceuticals Inc.
Pharmaceutical company2 products tracked
2
products tracked
24,798
total reports
1
recalls on record
97.9%
serious overall
Products
showing 2 of 2
| Product | Approved | Reports ↓ | Top signal | Recalls |
|---|---|---|---|---|
| 2004 | 12,399 | Dermatitis acneiform | 1 | |
| 2004 | 12,399 | Dermatitis acneiform | 0 |
Recall history · 1 on record
| Date | Class | Reason | Firm |
|---|---|---|---|
| Sep 15, 2014 | II | Failed Dissolution Specifications: The product did not meet the acceptance criteria for the dissolution test during the 24 month routine stability testing. | Astellas Pharma US Inc |
Class I = reasonable probability of serious harm · Class II = temporary or reversible · Class III = unlikely to cause harm.
Registration status
Some products from Armas Pharmaceuticals Inc. are not FDA-registered for human use. For unregistered substances (peptides, SARMs without human registration), no legitimate human-use supplier exists. The absence of a sourcing route is the safety information.